Senhwa Biosciences Collaborates with AI Firm CellType to Innovate Cancer Treatment Technologies Senhwa Biosciences has entered a strategic partnership with CellType, integrating AI to enhance the development of CX-4945 immunotherapy, aiming to reshape cancer treatment.

Senhwa Biosciences Collaborates with AI Firm CellType to Innovate Cancer Treatment Technologies #Taiwan #Taipei #Senhwa_Biosciences #CX-4945 #CellType

Thrilled to share this #epigenetics work comparing #Illumina #EPIC v1 and v2. Authors find significant readout differences in #EpigeneticClocks, #celltype, lifestyle #biomarkers between versions, and offer recommendations to mitigate version effects www.life-science-alliance.org/content/8/9/...